Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden · Delayed Price · Currency is SEK 2.600
-0.020 (-0.76%)
Jul 25, 2025, 5:29 PM CET
STO:NEWBRY Market Cap
STO:NEWBRY has a market cap or net worth of 79.03 million as of July 25, 2025. Its market cap has decreased by -5.84% in one year.
Market Cap
79.03M
Enterprise Value
67.36M
Revenue
46.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.60
Market Cap Chart
Since February 4, 2022, STO:NEWBRY's market cap has decreased from 245.97M to 79.03M, a decrease of -67.87%. That is a compound annual growth rate of -27.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 79.03M | -7.44% |
| Dec 30, 2024 | 85.39M | 42.48% |
| Dec 29, 2023 | 59.93M | -56.08% |
| Dec 30, 2022 | 136.45M | -44.52% |
| Feb 4, 2022 | 245.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 94.84B |
| Sectra AB | 69.33B |
| Getinge AB | 54.56B |
| Camurus AB | 42.22B |
| Medicover AB | 38.88B |
| Asker Healthcare Group AB | 38.40B |
| Bonesupport Holding AB | 21.17B |
| AddLife AB | 21.06B |